Ligand Pharmaceuticals (LGND) Capital Expenditures (2010 - 2026)
Ligand Pharmaceuticals recorded quarterly Capital Expenditures of $228000.0 in Q1 2026, up 6.05% quarter-over-quarter from $215000.0 in Q4 2025, and up 6.54% year-over-year from $214000.0 in Q1 2025.
Ligand Pharmaceuticals' Capital Expenditures history runs 17 years deep, the most recent figure standing at $228000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 6.54% year-over-year to $228000.0; the TTM figure through Mar 2026 stood at $229000.0 (down 19.08% YoY), while the FY2025 annual figure was $215000.0, up 202.82% from the prior year.
- Capital Expenditures came in at $228000.0 for Q1 2026 at Ligand Pharmaceuticals, up from $215000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $75.0 million in Q2 2024 to a low of -$74.7 million in Q3 2024.
- A 5-year average of $167470.6 and a median of $214000.0 in 2025 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 19032.14% in 2024 and fell as far as 3004.78% in 2024.
- Ligand Pharmaceuticals' Capital Expenditures stood at -$1.3 million in 2022, then slumped by 140.06% to -$3.1 million in 2023, then surged by 92.98% to -$218000.0 in 2024, then jumped by 198.62% to $215000.0 in 2025, then grew by 6.05% to $228000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $228000.0, $215000.0, and -$428000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Ligand Pharmaceuticals | 4.55 Bn | 3.77 Bn | 48.45 Mn | 228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228,000.00 |
| Mar 31, 2026 | 228,000.00 |
| Dec 31, 2025 | 215,000.00 |
| Dec 31, 2025 | 215,000.00 |
| Sep 30, 2025 | -428,000.00 |
| Sep 30, 2025 | -428,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Mar 31, 2025 | 214,000.00 |
| Mar 31, 2025 | 214,000.00 |
| Dec 31, 2024 | -218,000.00 |
| Dec 31, 2024 | -218,000.00 |
| Sep 30, 2024 | -74.71 Mn |
| Sep 30, 2024 | -74.71 Mn |
| Jun 30, 2024 | 75.00 Mn |
| Jun 30, 2024 | 75.00 Mn |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -3.10 Mn |
| Dec 31, 2023 | -3.10 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | 392,000.00 |
| Jun 30, 2023 | 392,000.00 |
| Mar 31, 2023 | 140,000.00 |
| Mar 31, 2023 | 140,000.00 |
| Dec 31, 2022 | -1.29 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -7.84 Mn |
| Sep 30, 2022 | -7.84 Mn |
| Jun 30, 2022 | 6.59 Mn |
| Jun 30, 2022 | 6.59 Mn |
| Mar 31, 2022 | 4.88 Mn |
| Mar 31, 2022 | 4.88 Mn |
| Dec 31, 2021 | 1.01 Mn |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | -4.24 Mn |
| Sep 30, 2021 | -4.24 Mn |
| Jun 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | 4.71 Mn |
| Mar 31, 2021 | 87,000.00 |
| Mar 31, 2021 | 87,000.00 |
| Dec 31, 2020 | -132,000.00 |
| Dec 31, 2020 | -132,000.00 |
| Sep 30, 2020 | 89,000.00 |
| Sep 30, 2020 | 89,000.00 |
| Jun 30, 2020 | 229,000.00 |
| Jun 30, 2020 | 229,000.00 |
| Mar 31, 2020 | 63,000.00 |
| Mar 31, 2020 | 63,000.00 |
| Dec 31, 2019 | 495,000.00 |
| Dec 31, 2019 | 495,000.00 |
| Sep 30, 2019 | -54,000.00 |
| Sep 30, 2019 | -54,000.00 |
| Jun 30, 2019 | -247,000.00 |
| Jun 30, 2019 | -247,000.00 |
| Mar 31, 2019 | 301,000.00 |
| Mar 31, 2019 | 301,000.00 |
| Dec 31, 2018 | 11,000.00 |
| Dec 31, 2018 | 11,000.00 |
| Sep 30, 2018 | -62,000.00 |
| Sep 30, 2018 | -62,000.00 |
| Jun 30, 2018 | 66,000.00 |
| Jun 30, 2018 | 66,000.00 |
| Dec 31, 2017 | 456,000.00 |
| Dec 31, 2017 | 456,000.00 |
| Sep 30, 2017 | 1.70 Mn |
| Sep 30, 2017 | 1.70 Mn |
| Jun 30, 2017 | -87,000.00 |
| Jun 30, 2017 | -87,000.00 |
| Mar 31, 2017 | 87,000.00 |
| Mar 31, 2017 | 87,000.00 |
| Dec 31, 2016 | 1.85 Mn |
| Dec 31, 2016 | 1.85 Mn |
| Sep 30, 2016 | -1.02 Mn |
| Sep 30, 2016 | -1.02 Mn |
| Jun 30, 2016 | 783,000.00 |
| Jun 30, 2016 | 783,000.00 |
| Mar 31, 2016 | 238,000.00 |
| Mar 31, 2016 | 238,000.00 |
| Dec 31, 2015 | 66,000.00 |
| Dec 31, 2015 | 66,000.00 |
| Jun 30, 2015 | 28,000.00 |
| Jun 30, 2015 | 28,000.00 |
| Mar 31, 2015 | -1,000.00 |
| Mar 31, 2015 | -1,000.00 |
| Dec 31, 2014 | 130,000.00 |
| Dec 31, 2014 | 130,000.00 |
| Sep 30, 2014 | 1,000.00 |
| Sep 30, 2014 | 1,000.00 |
| Jun 30, 2014 | -131,000.00 |
| Jun 30, 2014 | -131,000.00 |
| Mar 31, 2014 | 6,000.00 |
| Mar 31, 2014 | 6,000.00 |
| Dec 31, 2013 | 114,000.00 |
| Dec 31, 2013 | 114,000.00 |
| Sep 30, 2013 | 266,000.00 |
| Sep 30, 2013 | 266,000.00 |
| Jun 30, 2013 | -40,000.00 |
| Jun 30, 2013 | -40,000.00 |
| Mar 31, 2013 | 37,000.00 |
| Mar 31, 2013 | 37,000.00 |
| Dec 31, 2012 | -38,000.00 |
| Dec 31, 2012 | -38,000.00 |
| Sep 30, 2012 | 372,000.00 |
| Sep 30, 2012 | 372,000.00 |
| Jun 30, 2012 | 242,000.00 |
| Jun 30, 2012 | 242,000.00 |
| Mar 31, 2012 | 19,000.00 |
| Mar 31, 2012 | 19,000.00 |
| Dec 31, 2011 | -38,000.00 |
| Dec 31, 2011 | -38,000.00 |
| Sep 30, 2011 | 111,000.00 |
| Sep 30, 2011 | 111,000.00 |
| Mar 31, 2011 | 5,000.00 |
| Mar 31, 2011 | 5,000.00 |
| Sep 30, 2010 | 5,000.00 |
| Sep 30, 2010 | 5,000.00 |